Ca2+ fluxes involvement in gene expression during cardiac hypertrophy

Current Vascular Pharmacology

Volumn 11, Issue 4, 2013, Pages 497-506

  Gómez, Ana M ^a   Ruiz Hurtado, Gema ^b,c   Benitah, Jean Pierre ^a   Domínguez Rodríguez, Alejandro ^a  

^a Universite Paris Sud   (France)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Calcium; Cardiac hypertrophy; Excitation transcription coupling; Heart

Indexed keywords

ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR; BETA ADRENERGIC RECEPTOR; CALCIMYCIN; CALCINEURIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CHANNEL L TYPE; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT MODULATOR; DIACYLGLYCEROL; EPAC PROTEIN; GQ COUPLED RECEPTOR; HISTONE DEACETYLASE; INOSITOL 1, 4, 5 TRISPHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE P38; MYOCYTE ENHANCER FACTOR 2; NEUROHORMONE; NIFEDIPINE; PEPTIDES AND PROTEINS; PROTEIN KINASE C; RECEPTOR; SHAL POTASSIUM CHANNEL; STROMAL INTERACTION MOLECULE 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL 7; UNCLASSIFIED DRUG; VERAPAMIL;

ADRENERGIC STIMULATION; CALCIUM TRANSPORT; CYTOSOL; EXCITATION TRANSCRIPTION COUPLING; GENE EXPRESSION; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HUMAN; NONHUMAN; NUCLEAR REPROGRAMMING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; STIMULUS RESPONSE;

ALDOSTERONE; ANIMALS; CALCINEURIN; CALCIUM; CALCIUM CHANNELS, L-TYPE; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CALMODULIN; CARDIOMEGALY; CYCLIC AMP; GENE EXPRESSION REGULATION; HUMANS; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION;

EID: 84882739439     PISSN: 15701611     EISSN: 18756212     Source Type: Journal    
DOI: 10.2174/1570161111311040013     Document Type: Review

References (109)

1. Gómez AM, Valdivia HH, Cheng H, et al. Defective excitationcontraction coupling in experimental cardiac hypertrophy and heart failure. Science 1997;276 (5313):800-6.
2. Gómez AM, Guatimosim S, Dilly KW, Vassort G, Lederer WJ. Heart Failure After Myocardial Infarction: Altered Excitation-Contraction Coupling. Circulation 2001;104 (6):688-93.
3. Bénitah JP KB, Vassort G, Richard S, Gómez AM. Altered communication between L-type calcium channels and ryanodine receptors in heart failure. Front Biosci 2002;7:e263-75.
4. Bers DM. Calcium cycling and signaling in cardiac myocytes. Annu Rev Physiol 2008;70:23-49.
5. Anderson ME. Connections count: excitation-contraction meets excitation-transcription coupling. Circ Res 2000;86 (7):717-9.
6. Kannel WB. Incidence and epidemiology of heart failure. Heart Fail Rev 2000;5 (2):167-73.
7. Bénitah JP, Gómez AM, Bailly P, et al. Heterogeneity of the early outward current in ventricular cells isolated from normal and hypertrophied rat hearts. J Physiol (Lond) 1993;469:111-38.
8. Gómez AM, Schwaller B, Porzig H, Vassort G, Niggli E, Egger M. Increased Exchange Current but Normal Ca2+ Transport via Na+- Ca2+ Exchange During Cardiac Hypertrophy After Myocardial Infarction. Circ Res 2002;91 (4):323-30.
9. Schotten U, Koenigs B, Rueppel M, et al. Reduced myocardial sarcoplasmic reticulum Ca(2+)-ATPase protein expression in compensated primary and secondary human cardiac hypertrophy. J Mol Cell Cardiol 1999;31 (8):1483-94.
10. Lehnart SE, Schillinger W, Pieske B, Prestle J, Just H, Hasenfuss G. Sarcoplasmic reticulum proteins in heart failure. Ann N Y Acad Sci 1998;853:220-30.
11. Bénitah JP, Kerfant BG, Vassort G, Richard S, Gómez AM. Altered communication between L-type calcium channels and ryanodine receptors in heart failure. Front Biosci 2002;7:e263-75.
12. Richard S, Perrier E, Fauconnier J, et al. 'Ca(2+)-induced Ca(2+) entry' or how the L-type Ca(2+) channel remodels its own signalling pathway in cardiac cells. Prog Biophys Mol Biol 2006;90 (1-3):118-35.
13. Nass RD, Aiba T, Tomaselli GF, Akar FG. Mechanisms of disease: ion channel remodeling in the failing ventricle. Nat Clin Pract Cardiovasc Med 2008;5 (4):196-207.
14. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev 1999;79 (1):215-62.
15. Frey N, Katus HA, Olson EN, Hill JA. Hypertrophy of the heart: a new therapeutic target? Circulation 2004;109 (13):1580-9.
16. Berenji K, Drazner MH, Rothermel BA, Hill JA. Does loadinduced ventricular hypertrophy progress to systolic heart failure? Am J Physiol Heart Circ Physiol 2005;289 (1):H8-H16.
17. Gao Z, Xu H, DiSilvestre D, et al. Transcriptomic profiling of the canine tachycardia-induced heart failure model: global comparison to human and murine heart failure. J Mol Cell Cardiol 2006;40 (1):76-86.
18. Weber KT. Aldosterone in congestive heart failure. N Engl J Med 2001;345 (23):1689-97.
19. Movsesian MA, Bristow M. Alterations in cAMP-mediated signaling and their role in the pathophysiology of dilated cardiomyopathy. Curr Top Dev Biol. 2005;68:25-48.
20. Osadchii OE. Cardiac hypertrophy induced by sustained betaadrenoreceptor activation: pathophysiological aspects. Heart Fail Rev 2007;12 (1):66-86.
21. Adams JW, Brown JH. G-proteins in growth and apoptosis: lessons from the heart. Oncogene 2001;20 (13):1626-34.
22. de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A, Bos JL. Epac is a Rap1 guanine-nucleotideexchange factor directly activated by cyclic AMP. Nature 1998;396 (6710):474-7.
23. Bers DM. Going to cAMP just got more complicated. J Physiol 2007;583 (Pt 2):415-6.
24. Metrich M, Lucas A, Gastineau M, et al. Epac mediates betaadrenergic receptor-induced cardiomyocyte hypertrophy. Circ Res 2008;102 (8):959-65.
25. Morel E, Marcantoni A, Gastineau M, et al. cAMP-binding protein Epac induces cardiomyocyte hypertrophy. Circ Res 2005;97 (12):1296-304.
26. Kang G, Joseph JW, Chepurny OG, et al. Epac-selective cAMP analog 8-pCPT-2'-O-Me-cAMP as a stimulus for Ca2+-induced Ca2+ release and exocytosis in pancreatic beta-cells. J Biol Chem 2003;278 (10):8279-85.
27. Holz GG. Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell. Diabetes 2004;53 (1):5-13.
28. Enserink JM, Christensen AE, de Rooij J, van Triest M, Schwede F, Genieser HG, Doskeland SO, Blank JL, Bos JL. A novel Epacspecific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat Cell Biol 2002;4 (11):901-6.
29. Pereira L, Metrich M, Fernandez-Velasco M, et al. The cAMP binding protein Epac modulates Ca2+ sparks by a Ca2+/calmodulin kinase signalling pathway in rat cardiac myocytes. J Physiol 2007;583 (Pt 2):685-94.
30. Oestreich EA, Wang H, Malik S, et al. EPAC-mediated activation of phospholipase C plays a critical role in -adrenergic receptor dependent enhancement of Ca2+ mobilization in cardiac myocytes. J Biol Chem 2007;282:5488-95.
31. Oestreich EA, Malik S, Goonasekera SA, et al. Epac and phospholipase Cepsilon regulate Ca2+ release in the heart by activation of protein kinase Cepsilon and calcium-calmodulin kinase II. J Biol Chem 2009;284 (3):1514-22.
32. Cazorla O, Lucas A, Poirier F, Lacampagne A, Lezoualc'h F. The cAMP binding protein Epac regulates cardiac myofilament function. Proc Natl Acad Sci USA 2009;106 (33):14144-9.
33. Ulucan C, Wang X, Baljinnyam E, et al. Developmental changes in gene expression of Epac and its upregulation in myocardial hypertrophy. Am J Physiol Heart Circ Physiol 2007;293 (3):H1662-72.
34. Chen C, Du J, Feng W, et al. Beta-Adrenergic receptors stimulate interleukin-6 production through Epac-dependent activation of PKCdelta/p38 MAPK signalling in neonatal mouse cardiac fibroblasts. Br J Pharmacol 2011;166 (2):676-88.
35. Pereira L R-HG, Morel E, Laurent AC, et al. Epac enhances excitation-transcription coupling in cardiac myocytes. J Mol Cell Cardiol 2012;52:283-91.
36. Metrich M, Laurent AC, Breckler M, et al. Epac activation induces histone deacetylase nuclear export via a Ras-dependent signalling pathway. Cell Signal 2010;22 (10):1459-68.
37. Lewin G, Matus M, Basu A F et al. Critical role of transcription factor cyclic AMP response element modulator in beta1adrenoceptor-mediated cardiac dysfunction. Circulation 2009;119 (1):79-88.
38. Matus M, Lewin G, Stumpel F, et al. Cardiomyocyte-specific inactivation of transcription factor CREB in mice. FASEB J 2007;21 (8):1884-92.
39. Schulte JS, Seidl MD, Nunes F, et al. CREB critically regulates action potential shape and duration in the adult mouse ventricle. Am J Physiol Heart Circ Physiol 2012; 302(10): 1998-2007.
40. Mishra S, Ling H, Grimm M, Zhang T, Bers DM, Brown JH. Cardiac hypertrophy and heart failure development through Gq and CaM kinase II signaling. J Cardiovasc Pharmacol 2010;56 (6):598-603.
41. Lu J, McKinsey TA, Nicol RL, Olson EN. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc Natl Acad Sci USA 2000;97 (8):4070-5.
42. Wu X, Zhang T, Bossuyt J, et al. Local InsP3-dependent perinuclear Ca2+ signaling in cardiac myocyte excitation-transcription coupling. J Clin Invest 2006;116 (3):675-82.
43. Kockskamper J, Seidlmayer L, Walther S, Hellenkamp K, Maier LS, Pieske B. Endothelin-1 enhances nuclear Ca2+ transients in atrial myocytes through Ins(1,4,5)P3-dependent Ca2+ release from perinuclear Ca2+ stores. J Cell Sci 2008;121 (Pt 2):186-95.
44. Peng T, Shen E, Fan J, Zhang Y, Arnold JM, Feng Q. Disruption of phospholipase Cgamma1 signalling attenuates cardiac tumor necrosis factor-alpha expression and improves myocardial function during endotoxemia. Cardiovasc Res 2008;78 (1):90-7.
45. Puceat M, Jaconi M. Ca2+ signalling in cardiogenesis. Cell Calcium 2005;38 (3-4):383-9.
46. Eder P, Molkentin JD. TRPC channels as effectors of cardiac hypertrophy. Circ Res 2011;108 (2):265-72.
47. Wu X, Eder P, Chang B, Molkentin JD. TRPC channels are necessary mediators of pathologic cardiac hypertrophy. Proc Natl Acad Sci USA 2010;107 (15):7000-5.
48. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998;93 (2):215-28.
49. Heineke J, Molkentin JD. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 2006;7 (8):589-600.
50. Kuwahara K, Wang Y, McAnally J, et al. TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling. J Clin Invest 2006;116 (12):3114-26.
51. Wu X, Chang B, Blair NS, et al. Plasma membrane Ca2+-ATPase isoform 4 antagonizes cardiac hypertrophy in association with calcineurin inhibition in rodents. J Clin Invest 2009;119 (4):976-85.
52. Houser SR, Molkentin JD. Does contractile Ca2+ control calcineurin-NFAT signaling and pathological hypertrophy in cardiac myocytes? Sci Signal 2008;1 (25):pe31.
53. Hardingham GE, Arnold FJ, Bading H. Nuclear calcium signaling controls CREB-mediated gene expression triggered by synaptic activity. Nat Neurosci 2001;4 (3):261-7.
54. Deisseroth K, Heist EK, Tsien RW. Translocation of calmodulin to the nucleus supports CREB phosphorylation in hippocampal neurons. Nature 1998;392 (6672):198-202.
55. Dolmetsch RE, Pajvani U, Fife K, Spotts JM, Greenberg ME. Signaling to the nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase pathway. Science 2001;294 (5541):333-9.
56. Seth M, Zhang ZS, Mao L, et al. TRPC1 channels are critical for hypertrophic signaling in the heart. Circ Res 2009;105 (10):1023-30.
57. Bush EW, Hood DB, Papst PJ, et al. Canonical transient receptor potential channels promote cardiomyocyte hypertrophy through activation of calcineurin signaling. J Biol Chem 2006;281 (44):33487-96.
58. Nakayama H, Wilkin BJ, Bodi I, Molkentin JD. Calcineurindependent cardiomyopathy is activated by TRPC in the adult mouse heart. FASEB J 2006;20 (10):1660-70.
59. Onohara N, Nishida M, Inoue R, et al. TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy. EMBO J 2006;25 (22):5305-16.
60. Clapham DE. TRP channels as cellular sensors. Nature 2003;426 (6966):517-24.
61. Nilius B, Owsianik G, Voets T, Peters JA. Transient receptor potential cation channels in disease. Physiol Rev 2007;87 (1):165-217.
62. Abramowitz J, Birnbaumer L. Physiology and pathophysiology of canonical transient receptor potential channels. FASEB J 2009;23 (2):297-328.
63. Nishida M, Hara Y, Yoshida T, Inoue R, Mori Y. TRP channels: molecular diversity and physiological function. Microcirculation 2006;13 (7):535-50.
64. Hofmann T, Obukhov AG, Schaefer M, Harteneck C, Gudermann T, Schultz G. Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. Nature 1999;397 (6716):259-63.
65. Luo X, Hojayev B, Jiang N, et al. STIM1-dependent store-operated Ca(2) entry is required for pathological cardiac hypertrophy. J Mol Cell Cardiol 2012;52 (1):136-47.
66. Frischauf I, Schindl R, Derler I, Bergsmann J, Fahrner M, Romanin C. The STIM/Orai coupling machinery. Channels (Austin) 2008;2 (4):261-8.
67. Yuan JP, Zeng W, Huang GN, Worley PF, Muallem S. STIM1 heteromultimerizes TRPC channels to determine their function as store-operated channels. Nat Cell Biol 2007;9 (6):636-45.
68. Liao Y, Plummer NW, George MD, Abramowitz J, Zhu MX, Birnbaumer L. A role for Orai in TRPC-mediated Ca2+ entry suggests that a TRPC:Orai complex may mediate store and receptor operated Ca2+ entry. Proc Natl Acad Sci USA 2009;106 (9):3202-6.
69. Pani B, Ong HL, Liu X, Rauser K, Ambudkar IS, Singh BB. Lipid rafts determine clustering of STIM1 in endoplasmic reticulumplasma membrane junctions and regulation of store-operated Ca2+ entry (SOCE). J Biol Chem 2008;283 (25):17333-40.
70. DeHaven WI, Jones BF, Petranka JG, et al. TRPC channels function independently of STIM1 and Orai1. J Physiol 2009;587 (Pt 10):2275-98.
71. Luetscher JA, Jr., Johnson BB. Observations on the sodiumretaining corticoid (aldosterone) in the urine of children and adults in relation to sodium balance and edema. J Clin Invest 1954;33 (11):1441-6.
72. Davis JO, Pechet MM, Ball WC, Jr., Goodkind MJ. Increased aldosterone secretion in dogs with right-sided congestive heart failure and in dogs with thoracic inferior vena cava constriction. J Clin Invest 1957;36 (5):689-94.
73. McKelvie RS, Yusuf S, Pericak D, et al. Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators. Circulation 1999;100 (10):1056-64.
74. Swedberg K, Eneroth P, Kjekshus J, Snapinn S. Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (follow-up of the CONSENSUS trial). CONSENSUS Trial Study Group. Am J Cardiol 1990;66 (11):40D-4D; discussion 4D-5D.
75. Guder G, Bauersachs J, Frantz S, et al. Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure. Circulation 2007;115 (13):1754-61.
76. Pitt B. Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies. Mol Cell Endocrinol 2004;217 (1-2):53-8.
77. Zannad F, McMurray JJ, Krum H, et al. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 2011;364 (1):11-21.
78. Dooley R, Harvey BJ, Thomas W. The regulation of cell growth and survival by aldosterone. Front Biosci 2011;16:440-57.
79. Bénitah JP, Vassort G. Aldosterone upregulates Ca(2+) current in adult rat cardiomyocytes. Circ Res 1999;85 (12):1139-45.
80. Gomez AM, Rueda A, Sainte-Marie Y, et al. Mineralocorticoid Modulation of Cardiac Ryanodine Receptor Activity Is Associated With Downregulation of FK506-Binding Proteins. Circulation 2009;119 (16):2179-U89.
81. Perrier E, Perrier R, Richard S, Bénitah JP. Ca2+ controls functional expression of the cardiac K+ transient outward current via the calcineurin pathway. J Biol Chem 2004;279 (39):40634-9.
82. Bénitah JP, Gómez AM, Virsolvy A, Richard S. New perspectives on the key role of calcium in the progression of heart disease. J Muscle Res Cell Motil 2003;24 (4-6):275-83.
83. Marx SO, Reiken S, Hisamatsu Y, et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 2000;101 (4):365-76.
84. Gómez AM, Bénitah JP, Henzel D, Vinet A, Lorente P, Delgado C. Modulation of electrical heterogeneity by compensated hypertrophy in rat left ventricle. Am J Physiol 1997;272 (3 Pt 2):H1078-86.
85. Perrier E, Kerfant B, Vassort G, Rossier M, Gomez AM, Benitah JP. Aldosterone-antagonist prevents ionic remodelling that precedes cardiac hypertrophy. Biophys J 2003;84 (2):423A-A.
86. McDermott P, Daood M, Klein I. Contraction regulates myosin synthesis and myosin content of cultured heart cells. Am J Physiol 1985;249 (4 Pt 2):H763-9.
87. McDermott PJ, Carl LL, Conner KJ, Allo SN. Transcriptional regulation of ribosomal RNA synthesis during growth of cardiac myocytes in culture. J Biol Chem 1991;266 (7):4409-16.
88. Samarel AM, Engelmann GL. Contractile activity modulates myosin heavy chain-beta expression in neonatal rat heart cells. Am J Physiol 1991;261 (4 Pt 2):H1067-77.
89. Sei CA, Irons CE, Sprenkle AB, McDonough PM, Brown JH, Glembotski CC. The alpha-adrenergic stimulation of atrial natriuretic factor expression in cardiac myocytes requires calcium influx, protein kinase C, and calmodulin-regulated pathways. J Biol Chem 1991;266 (24):15910-6.
90. McDonough PM, Glembotski CC. Induction of atrial natriuretic factor and myosin light chain-2 gene expression in cultured ventricular myocytes by electrical stimulation of contraction. J Biol Chem 1992;267 (17):11665-8.
91. Atar D, Backx PH, Appel MM, Gao WD, Marbán E. Excitationtranscription coupling mediated by zinc influx through voltagedependent calcium channels. J Biol Chem 1995;270 (6):2473-7.
92. Taouis M, Sheldon RS, Duff HJ. Upregulation of the rat cardiac sodium channel by in vivo treatment with a class I antiarrhythmic drug. J Clin Invest 1991;88 (2):375-8.
93. Duff HJ, Offord J, West J, Catterall WA. Class I and IV antiarrhythmic drugs and cytosolic calcium regulate mRNA encoding the sodium channel alpha subunit in rat cardiac muscle. Mol Pharmacol 1992;42 (4):570-4.
94. Chiamvimonvat N, Kargacin ME, Clark RB, Duff HJ. Effects of intracellular calcium on sodium current density in cultured neonatal rat cardiac myocytes. J Physiol 1995;483 (Pt 2):307-18.
95. Davidoff AJ, Maki TM, Ellingsen O, Marsh JD. Expression of calcium channels in adult cardiac myocytes is regulated by calcium. J Mol Cell Cardiol 1997;29 (7):1791-803.
96. Nishiyama T, Kobayashi A, Haga T, Yamazaki N. Chronic treatment with nifedipine does not change the number of [3H]nitrendipine and [3H]dihydroalprenolol binding sites. Eur J Pharmacol 1986;121 (2):167-72.
97. Gengo P, Skattebol A, Moran JF, Gallant S, Hawthorn M, Triggle DJ. Regulation by chronic drug administration of neuronal and cardiac calcium channel, beta-adrenoceptor and muscarinic receptor levels. Biochem Pharmacol 1988;37 (4):627-33.
98. Schroder E, Magyar J, Burgess D, Andres D, Satin J. Chronic verapamil treatment remodels ICa,L in mouse ventricle. Am J Physiol Heart Circ Physiol 2007;292 (4):H1906-16.
99. Morgan PE, Aiello EA, Chiappe de Cingolani GE, Mattiazzi AR, Cingolani HE. Chronic administration of nifedipine induces upregulation of functional calcium channels in rat myocardium. J Mol Cell Cardiol 1999;31 (10):1873-83.
100. Chapados RA, Gruver EJ, Ingwall JS, Marsh JD, Gwathmey JK. Chronic administration of cardiovascular drugs: altered energetics and transmembrane signaling. Am J Physiol 1992;263 (5 Pt 2):H1576-86.
101. Chiappe De Cingolani GE, Mosca SM, Vila Petroff M, Cingolani HE. Chronic administration of nifedipine induces upregulation of dihydropyridine receptors in rabbit heart. Am J Physiol 1994;267 (3 Pt 2):H1222-6.
102. de Cingolani GE, Mosca SM, Moreyra AE, Cingolani HE. Chronic nifedipine treatment diminishes cardiac inotropic response to nifedifine: functional upregulation of dihydropyridine receptors. J Cardiovasc Pharmacol 1996;27 (2):240-6.
103. Gong N, Bodi I, Zobel C, Schwartz A, Molkentin JD, Backx PH. Calcineurin increases cardiac transient outward K+ currents via transcriptional up-regulation of Kv4.2 channel subunits. J Biol Chem 2006;281 (50):38498-506.
104. Rossow CF, Dilly KW, Santana LF. Differential calcineurin/NFATc3 activity contributes to the Ito transmural gradient in the mouse heart. Circ Res 2006;98 (10):1306-13.
105. Rossow CF, Minami E, Chase EG, Murry CE, Santana LF. NFATc3-induced reductions in voltage-gated K+ currents after myocardial infarction. Circ Res 2004;94 (10):1340-50.
106. Xiao L, Coutu P, Villeneuve LR, et al. Mechanisms underlying rate-dependent remodeling of transient outward potassium current in canine ventricular myocytes. Circ Res 2008;103 (7):733-42.
107. Gomez-Ospina N, Tsuruta F, Barreto-Chang O, Hu L, Dolmetsch R. The C terminus of the L-type voltage-gated calcium channel Ca(V)1.2 encodes a transcription factor. Cell 2006;127 (3):591-606.
108. Schroder E, Byse M, Satin J. L-type calcium channel C terminus autoregulates transcription. Circ Res 2009;104 (12):1373-81.
109. Dolmetsch R. Excitation-transcription coupling: signaling by ion channels to the nucleus. Sci STKE 2003;2003 (166):PE4.